{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:12:46Z","timestamp":1785427966120,"version":"3.56.0"},"reference-count":32,"publisher":"Scientific Scholar","issue":"01","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Hematopoietic stem cell transplantation (HSCT) is the preferred treatment for high-risk and relapsed\/refractory hematological malignancies. Moreover, with the improved supportive care and increasing acceptance of haploidentical transplantations as an alternative treatment modality, more patients are opting for HSCT as a definite treatment for hematological malignancies. We report here the real-world data and outcome of HSCT done for hematological malignancies at our transplant center. Five hundred and sixteen patients underwent HSCT from August 2010 to November 2019. The most common indications for allogeneic and autologous HSCT were acute myeloid leukemia and multiple myeloma, respectively. The 5-year overall survival and disease-free survival for all transplants were 65% and 33%, respectively. Though outcome of matched sibling donor allogeneic transplant is better than haploidentical donor (HID) transplant, patients having only HID can still be considered for allogeneic HSCT for high-risk diseases. The most common cause of death was infections followed by relapse of the disease.<\/jats:p>","DOI":"10.1055\/s-0041-1731599","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T21:27:38Z","timestamp":1634419658000},"page":"062-067","source":"Crossref","is-referenced-by-count":5,"title":["Hematopoietic Stem Cell Transplant for Hematological Malignancies: Experience from a Tertiary Care Center in Northern India and Review of Indian Data"],"prefix":"10.25259","volume":"11","author":[{"given":"Sanjeev Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplant, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharma","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplant, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Doval","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplant, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Khandelwal","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplant, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-6871","authenticated-orcid":false,"given":"Rasika","family":"Setia","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplant, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dadu","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplant, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Handoo","sequence":"additional","affiliation":[{"name":"Center for Bone Marrow Transplant, BLK Super Speciality Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"A Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"e2014046","DOI":"10.4084\/mjhid.2014.046","article-title":"Cost of hematopoietic stem cell transplantation in India","volume":"6","author":"S K Sharma","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12288-017-0876-y","article-title":"Autologous stem cell transplantation for multiple myeloma: single centre experience from North India","volume":"34","author":"P Malhotra","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4103\/ijmr.IJMR_1593_18","article-title":"for AIIMS Myeloma Group. High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: predictors of long-term outcome","volume":"149","author":"L Kumar","year":"2019","journal-title":"Indian J Med Res"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12288-018-0989-y","article-title":"Clinical outcomes in multiple myeloma post-autologous transplantation-a single centre experience","volume":"35","author":"U Kulkarni","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"S 01","key":"ref6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000447577","article-title":"Epidemiology of non-Hodgkin's lymphoma in India","volume":"91","author":"R Nair","year":"2016","journal-title":"Oncology"},{"issue":"S 01","key":"ref7","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/annonc\/9.suppl_1.S9","article-title":"High-dose therapy for diffuse large-cell lymphoma in first remission","volume":"9","author":"A R Perry","year":"1998","journal-title":"Ann Oncol"},{"issue":"23","key":"ref8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"T Philip","year":"1995","journal-title":"N Engl J Med"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00277-012-1491-5","article-title":"B cell non-Hodgkin's lymphoma: experience from a tertiary care cancer center","volume":"91","author":"G Prakash","year":"2012","journal-title":"Ann Hematol"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/bjh.15412","article-title":"How I manage patients with relapsed\/refractory diffuse large B cell lymphoma","volume":"182","author":"C Gisselbrecht","year":"2018","journal-title":"Br J Haematol"},{"issue":"06","key":"ref11","first-page":"330","article-title":"Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome","volume":"23","author":"L Kumar","year":"2010","journal-title":"Natl Med J India"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbmt.2015.02.005","article-title":"Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation","volume":"21","author":"Y-B Chen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/2278-330X.126531","article-title":"Management of relapsed-refractory diffuse large B cell lymphoma","volume":"3","author":"L S Raut","year":"2014","journal-title":"South Asian J Cancer"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JGO.2016.006650","article-title":"Allogeneic stem cell transplant for acute myeloid leukemia: evolution of an effective strategy in India","volume":"3","author":"A Ganapule","year":"2017","journal-title":"J Glob Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-020-01386-6","article-title":"Myeloablative versus reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplant for acute myeloid leukemia and myelodysplastic syndrome: a retrospective analysis","volume":"\u2022\u2022\u2022","author":"S K Sharma","year":"2020","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"e13918","DOI":"10.1111\/petr.13918","article-title":"Allogeneic hematopoietic stem cell transplant in pediatric acute myeloid leukemia: lessons learnt from a tertiary care center in India","volume":"25","author":"S Arora","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.seminhematol.2015.03.005","article-title":"Alternative donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"52","author":"C G Kanakry","year":"2015","journal-title":"Semin Hematol"},{"issue":"25","key":"ref18","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study","volume":"125","author":"Y Wang","year":"2015","journal-title":"Blood"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/leu.2015.232","article-title":"Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?","volume":"30","author":"O Ringd\u00e9n","year":"2016","journal-title":"Leukemia"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.bbmt.2019.12.638","article-title":"Hematopoietic stem cell transplant outcomes in patients with acute myeloid leukemia from a tertiary care center in South India","volume":"26","author":"K S Nataraj","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbmt.2015.11.010","article-title":"Haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in children with advanced acute leukemia with fludarabine-, busulfan-, and melphalan-based conditioning","volume":"22","author":"S R Jaiswal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5726132","DOI":"10.1155\/2016\/5726132","article-title":"Review on haploidentical hematopoietic cell transplantation in patients with hematologic malignancies","volume":"2016","author":"W A Fabricius","year":"2016","journal-title":"Adv Hematol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.9734\/ibrr\/2020\/v11i430137","article-title":"What a clinical hematologist should know about T cells?","author":"S K Sharma","year":"2020","journal-title":"Int Blood Res Rev"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.clml.2017.03.228","article-title":"High dose chemotherapy with autologous stem cell transplantation for multiple myeloma: outcomes at Tata Memorial Centre","volume":"17","author":"A Gokarn","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref25","first-page":"1010","article-title":"Stem cell transplant for multiple myeloma: a single center experience from Northern India","volume":"31","author":"S K Sharma","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00277-018-3370-1","article-title":"Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma","volume":"97","author":"M Aggarwal","year":"2018","journal-title":"Ann Hematol"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12288-018-0951-z","article-title":"Autologous hematopoietic stem cell transplantation for multiple myeloma in India","volume":"34","author":"R Naithani","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12288-019-01111-y","article-title":"Stem cell transplantation in multiple myeloma: very much alive and kicking","volume":"35","author":"U Yanamandra","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1016\/j.clml.2019.07.312","article-title":"Autologous Stem cell transplantation in multiple myeloma: experience of a single center from Eastern India","volume":"19","author":"J Kumar","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12288-015-0559-5","article-title":"Improving outcome of Hodgkin's disease with autologous hematopoietic stem cell transplantation","volume":"32","author":"S Raut","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref31","first-page":"710543","article-title":"Hematopoietic stem-cell transplantation in the developing world: experience from a center in Western India","volume":"2015","author":"C A Shah","year":"2015","journal-title":"J Oncol"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijc.IJC_656_17","article-title":"Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: an institutional audit","volume":"55","author":"N Khattry","year":"2018","journal-title":"Indian J Cancer"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1731599.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:26Z","timestamp":1781176346000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/hematopoietic-stem-cell-transplant-for-hematological-malignancies-experience-from-a-tertiary-care-center-in-northern-india-and-review-of-indian-data\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":32,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2022,7,11]]},"published-print":{"date-parts":[[2022,1]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1731599","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}